Wegovy (semaglutide) pills became available in January 2025 in 1.5 mg, 4 mg, 9 mg, and 25 mg doses. It is a medication that is FDA-approved for weight loss in individuals who meet certain criteria*, and originally was available only via injectable pen. The Wegovy pill is available with insurance coverage under specific plans, and also available via cash pay at a discount, making them more accessible to individuals without insurance coverage or those ineligible for savings programs. Wegovy pill works by activating the receptors of the glucagon-like peptide-1 (GLP-1) hormone, helping to reduce appetite and food intake, and supporting long-term weight management. Clinical studies show that patients using the Wegovy pill, along with a reduced-calorie diet and increased physical activity, achieved an average of 14% weight loss over 64 weeks. ‍
*BMI 30+ or 27+ with weight related medical conditions such as high blood pressure, high cholesterol, etc.

Wegovy® is a registered trademark of Novo Nordisk A/S.

Wegovy (semaglutide) pills are available for cash pay via Novocare Pharmacy and through commercial insurance. In some cases, the Wegovy pill may be a more affordable option for many than the once-weekly injectable pen. Coverage and cost depend on individual insurance coverage and plan. For those without plan coverage, cash-pay prices through Novocare Pharmacy vary by dose prescribed by your physician. For questions regarding the out-of-pocket cost of the Wegoy® pill and to determine your exact financial responsibility, it is highly recommended that you contact your insurance provider directly using the member services number located on the back of your insurance card.

Wegovy® is a registered trademark of Novo Nordisk A/S.

The Wegovy pill is a once-daily oral medication taken by mouht. It is recommended to take the Wegovy (semaglutide) pill first thing in the morning on an empty stomach with a sip of water up to 4 ounces. Wait 30 minutes before eating, drinking, or taking other oral medications.

Always follow your healthcare clinician’s instructions and consult with them on any questions. For your health and safety, please alert your prescribing clinician to any side effects you may experience. Your clinician will be able to provide personalized suggestions and make adjustments to your treatment plan. 

‍
Wegovy® is a registered trademark of Novo Nordisk A/S.

To get a prescription for Wegovy (semaglutide) pills, you must meet certain criteria. Wegovy is FDA-approved for weight loss for adults with a BMI of 30+ or 27-29.9 with at least one weight-related comorbidity, such as heart disease, obstructive sleep apnea, high cholesterol, or high blood pressure. It is to be used in combination with a reduced-calorie diet and increased physical activity. Your healthcare clinician should also take into consideration other aspects of your medical history to ensure you are a good candidate for this medication.

If eligible, your healthcare clinician will send a prescription for Wegovy pills. The Wegovy pills are available for cash pay through Novocare Pharmacy and are available via local pharmacies with insurance.

Wegovy® is a registered trademark of Novo Nordisk A/S.